Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04521686
Title Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | AUS

Facility Status City State Zip Country Details
Mayo Clinic of Scottsdale Phoenix Arizona 85054 United States Details
The University of Arizona Cancer Center Tucson Arizona 85724 United States Details
USC Norris Cancer Hospital Los Angeles California 90033 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224 United States Details
University of Chicago Pritzker School of Medicine Chicago Illinois 60637 United States Details
Indiana University School of Medicine Indianapolis Indiana 46202 United States Details
The John Hopkins Hospital Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
Memorial Sloan Kettering Cancer Center Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
St Vincent's Hospital Sydney Darlinghurst New South Wales 2010 Australia Details
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest Bordeaux 33076 France Details
Gustave Roussy Villejuif Cedex 94805 France Details
Prince of Wales Hospital Hong Kong Shatin, New Territories Hong Kong Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
Kanagawa Cancer Center Yokohama Kanagawa 241-8515 Japan Details
Osaka University Hospital Suita-shi Osaka 565-0871 Japan Details
Shizuoka Cancer Center Nagaizumi Shizuoka 411-8777 Japan Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
Samsung Medical Center Seoul Seoul-teukbyeolsi [Seoul] 06351 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
National University Hospital Singapore 669606 Singapore Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
China Medical University Hospital Taichung City 40447 Taiwan Details
National Cheng-Kung Uni. Hosp. Tainan 704 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field